Our fourth Changing Faces round-up is one that we don’t always publish, but in May and June we heard about enough hires in the public sector, non-profit, and academic worlds to stand in the
Gilead Sciences' chief medical officer, Merdad Parsey, will leave the company in early 2025, becoming the latest in a series of high-profile departures involving senior R&D figures at t
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Luca Quagliata, Vice President and Global Head of Medical and Scientific Affairs at Thermo Fisher Scientific, a company